Premium
Inhibition of the p38 pathway upregulates macrophage JNK and ERK activities, and the ERK, JNK, and p38 MAP kinase pathways are reprogrammed during differentiation of the murine myeloid M1 cell line
Author(s) -
Hall J. Perry,
Davis Roger J.
Publication year - 2002
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.10187
Subject(s) - mapk/erk pathway , p38 mitogen activated protein kinases , microbiology and biotechnology , kinase , mitogen activated protein kinase , map kinase kinase kinase , mitogen activated protein kinase kinase , mapk14 , biology , chemistry , protein kinase a
Mitogen‐activated protein (MAP) kinases have been implicated as important mediators of the inflammatory response. Here we report that c‐Jun NH 2 ‐terminal kinase (JNK), extracellular signal‐regulated kinase (ERK), and p38 MAP kinase activities are reprogrammed during the IL‐6 induced macrophage‐like differentiation of the murine myeloid M1 cell line. Moreover, p38 inhibition upregulates JNK and ERK activity in M1 cells and in thioglycollate‐elicited peritoneal exudate macrophages. IL‐6‐induced M1 differentiation also induces expression of the anti‐inflammatory cytokine IL‐10, and p38 inhibition potentiates this increase in IL‐10 expression in an ERK‐dependent manner. Thus, we speculate that during inflammatory conditions in vivo macrophage p38 may regulate JNK and ERK activity and inhibit IL‐10 expression. These data highlight the importance of p38 in the molecular mechanisms of macrophage function. J. Cell. Biochem. 86: 1–11, 2002. © 2002 Wiley‐Liss, Inc.